Connecticut to Get More Than $1M in Amgen Settlement – Connecticut Law Tribune
Connecticut Law TribuneConnecticut to Get More Than $1M in Amgen SettlementConnecticut Law TribuneThe other biologic medicine, Enbrel, is approved by the FDA for the treatment of certain types of arthritis and chronic moderate to severe plaque psoriasis in adults. The states alleged Amgen overstated Enbrel's effectiveness and lacked competent and …
[monetize id=”1″] [monetize id=”2″]
Arizona, other states, reach $71 million settlement with drug maker – azcentral.com
TIMEArizona, other states, reach $71 million settlement with drug makerazcentral.com•Promoting Aranesp for anemia caused by cancer without FDA approval. •Promoting Enbrel for mild plaque psoriasis, though the FDA approved it only for chronic moderate to severe plaque psoriasis. Anemia is a condition that causes people to feel tired …Indiana to receive $1.3 million in global pharmaceutical settlement21AliveAmgen paying $71M in off-label drug marketing caseSFGatePharmaceutical Giant Amgen Settles for $71 Million For Misleading ConsumersTIMELas Vegas Review-Journal -ConsumerAffairsall 203 news articles »
https://www.dpsw.org/psoriasis-cure
